
- Vol 37, Issue 6
- Volume 37
- Issue 6
The Case Against Antidepressants for Bipolar Depression: Findings from STEP-BD
Do you prescribe antidepressants for your patients with bipolar depression? If so, think again, and consider results from these studies.
BIPOLAR UPDATE
Do you prescribe antidepressants for your patients with bipolar depression? If so, think again, and consider results from the Systematic Treatment Enhancement Program–Bipolar Disorder (
Among the significant findings were the following:
1. Antidepressants (bupropion, paroxetine) are not more effective than placebo for bipolar depression (24% for the antidepressants versus 27% for the placebo in a 6-month trial).1 The antidepressants, when added to a mood stabilizer, did not induce more switches into mania (10% versus 11%), but the patients who participated in the study were probably at very low risk for switching. However, patients with bipolar depression with mixed features (defined as having 2 or more manic symptoms [eg, agitation and racing thoughts] with their depression) developed manias over the next several months that were more severe as compared with placebo-treated patients.
2. A group of 86 patients with bipolar disorder who responded to an antidepressant when depressed were identified. Some were rapid cyclers (4 or more episodes per year). All of the patients were also prescribed mood stabilizers such as lithium, valproate, or a second-generation antipsychotic. These patients were randomized to stay on the antidepressants or discontinue them. The patients with rapid cycling who were continued on their antidepressant had triple the number of depressions per year compared with those without rapid cycling. Yet, there was no difference in the rate of depressions between rapid and non-rapid cycling in the antidepressant discontinuation group. Thus, depressive morbidity and cycling were worsened by continuation of an antidepressant in patients with rapid cycling.2
3. In another STEP-BD study,
Conclusion
Findings from STEP-BD studies indicate that antidepressants should be avoided in most cases when treating acute depression in patients with bipolar disorder. Rather, one should choose from among 5 medications with a reasonable evidence-base for effectiveness and safety in treating or at least preventing bipolar depressions, namely: lithium, quetiapine, lamotrigine, lurasidone, and cariprazine—or combinations of these.
Disclosures:
Dr Osser is Associate Professor of Psychiatry, Harvard Medical School, and Consulting Psychiatrist, US Department of Veterans Affairs, National Telemental Health Center, Bipolar Disorders Telehealth Program, Brockton, MA.
References
1. Sachs GS, Neirenberg AA, Calabrese JR, et al.
2. El-Mallakh RH, Vöhringer PA, Ostacher MM, et al.
3 El-Mallakh RH, Ghaemi SN, Sagduyu K, et al.
This article was originally posted on April 24, 2020, and has since been updated. -Ed
Articles in this issue
over 5 years ago
Meeting Patients Where They Are: A Public Health Imperativeover 5 years ago
Prescribing Hope for Recoveryover 5 years ago
Stage-Specific Treatment of Psychotic Disordersover 5 years ago
Investing Tips in a Time of Crisisover 5 years ago
Talking to Pregnant Patients About Cannabis Useover 5 years ago
In Memoriam: Psychiatrists Who Are Coronavirus Casualtiesover 5 years ago
The Future of Telepsychiatryover 5 years ago
Immigrantover 5 years ago
Exploring Psychotropic Drug InteractionsNewsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.